FORMULATIONS D'ANTICORPS
The present application describes antibody formulations, including monoclonal antibodies formulated in histidine-acetate buffer, as well as a formulation comprising an antibody that binds to domain II of HER2 (for example, Pertuzumab), and a formulation comprising an antibody that binds to DR5 (for...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | French |
Published |
01.11.2007
|
Edition | 7 |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!